AI could revolutionize cancer diagnosis with new pathology model
NCT ID NCT07157618
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is developing an artificial intelligence (AI) model to help doctors diagnose cancer more accurately by analyzing pathology slides and patient data. Researchers will collect information from 2000 adults with various cancers to train and test the AI. The goal is to create a tool that can grade tumors, classify molecular subtypes, and guide chemotherapy decisions, ultimately improving patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- deep learning-based pathology foundation model
- What this could lead to
- If successful, this could lead to a more accurate and efficient AI tool to help pathologists diagnose cancer and guide treatment decisions.
- What could go wrong
- This is an early-stage development study. The AI model may not perform well enough in real-world settings, and results may not apply to all cancer types or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
-
Qianfoshan Hospital
RECRUITINGJinan, Shandong, 250014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.